20.4 ICU Sedation, Delirium, Weaning, and Brain Death Determination

20.4 ICU Sedation, Delirium, Weaning, and Brain Death Determination

Critical care management encompasses the continuum from patient comfort and neurocognitive protection to liberation from mechanical ventilation and the rigorous, protocolized determination of death by neurological criteria. Candidates for the EDAIC Part I examination must possess in-depth knowledge of sedation pharmacology, delirium screening algorithms, extubation predictors, and the legal-medical prerequisites of brain death.

---

The PADIS Clinical Practice Guidelines: Analgosedation

The Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption (PADIS) guidelines endorse an analgesia-first ("analgosedation") model of critical care sedation.

1. Analgesia-First Model

• Pain is the primary driver of physiological stress, tachycardia, hypertension, ventilator fighting, sleep disruption, and post-traumatic stress disorder in critically ill patients.
• Analgosedation prioritizes assessing and treating pain with intravenous opioids (e.g., remifentanil, fentanyl, hydromorphone) before administering hypnotic sedatives. In many postoperative and mechanically ventilated patients, adequate analgesia eliminates the requirement for sedative infusions entirely.
• Pain Assessment: Validated behavioral scoring systems are required for non-verbal, mechanically ventilated patients: the Behavioral Pain Scale (BPS) (scored 3–12 based on facial expression, upper limb movements, and ventilator compliance) or the Critical-Care Pain Observation Tool (CPOT) (scored 0–8).

2. Light Sedation Targets

• Clinical trials demonstrate that light sedation (patient is responsive to verbal commands, able to maintain eye contact, and can participate in care) is associated with shorter duration of mechanical ventilation, reduced ICU length of stay, and lower rates of tracheostomy compared to deep sedation.
• Standardized Sedation Scales:
  • Richmond Agitation-Sedation Scale (RASS): Target score of $-1\text{ (drowsy)}$ to $0\text{ (alert and calm)}$.
  • Riker Sedation-Agitation Scale (SAS): Target score of $3\text{ to }4$.

3. Daily Sedation Interruption (DSI) and the ABCDEF Bundle

• Daily Sedation Interruption (Spontaneous Awakening Trials / SAT): Daily cessation or reduction of sedative infusions until the patient is awake and able to execute simple commands (or develops marked agitation/respiratory distress). Paired with Spontaneous Breathing Trials (SBT), SAT significantly accelerates ventilator liberation.
• The ABCDEF Interprofessional Bundle:
  • A: Assess, prevent, and manage pain
  • B: Both Spontaneous Awakening Trials (SAT) and Spontaneous Breathing Trials (SBT)
  • C: Choice of analgesia and sedation (avoiding benzodiazepines)
  • D: Delirium: assess, prevent, and manage
  • E: Early mobility and exercise
  • F: Family engagement and empowerment

---

Pharmacology of Common ICU Sedative Agents

---

Delirium in the Intensive Care Unit: Subtypes and CAM-ICU

Delirium is an acute, fluctuating disturbance in attention, awareness, and baseline cognition. It affects up to $80\%$ of mechanically ventilated ICU patients and independently predicts prolonged hospitalization, long-term cognitive impairment, and increased 6-month mortality.

1. Clinical Subtypes of Delirium

• Hypoactive Delirium ($50-60\%$ of cases): Characterized by lethargy, psychomotor slowing, apathy, and decreased responsiveness. Frequently misdiagnosed as depression, fatigue, or over-sedation ("quiet delirium"). Carries the highest hospital mortality and poorest long-term neurocognitive prognosis.
• Hyperactive Delirium ($<10-15\%$ of cases): Characterized by psychomotor agitation, combativeness, hallucinations, emotional lability, and dangerous pulling at endotracheal tubes and vascular catheters.
• Mixed Delirium ($30-40\%$ of cases): Demonstrates fluctuations between hyperactive and hypoactive states over a 24-hour cycle.

2. Confusion Assessment Method for the ICU (CAM-ICU)

The CAM-ICU is the standard bedside screening tool. It can only be assessed if the patient is sufficiently arousable to verbal stimulation (i.e., RASS score $\ge -3$). If the patient is deeply sedated or comatose (RASS $-4$ or $-5$), delirium assessment is deferred.

CAM-ICU Diagnostic Algorithm (Evaluated when RASS >= -3):

[Feature 1: Acute Onset or Fluctuating Course] ──(Must be Present)──┐
                                                                   │
[Feature 2: Inattention (Letter Test)] ─────────(Must be Present)──┼──> DELIRIUM POSITIVE
                                                                   │    (Requires 1 + 2 and
       ┌───────────────────────────────────────────────────────────┘     EITHER 3 or 4)
       ▼
[Feature 3: Altered Level of Consciousness (Current RASS != 0)]
       OR
[Feature 4: Disorganized Thinking (> 1 error on logic questions)]

• Feature 1: Acute Onset or Fluctuating Course: Evidence of an acute change in mental status from baseline, OR fluctuations in mental status over the preceding 24 hours (e.g., fluctuating RASS scores).
• Feature 2: Inattention: Assessed via the auditory Attention Screening Examination (ASE): the clinician reads 10 letters ("S-A-V-E-A-H-A-A-R-T") and instructs the patient to squeeze their hand on the letter "A". More than 2 errors (squeezing on a non-A letter or failing to squeeze on "A") indicates inattention.
• Feature 3: Altered Level of Consciousness: Evaluated simply by the patient's current sedation level. Any current RASS score other than $0\text{ (alert and calm)}$ (e.g., $+1$, $+2$, $-1$, $-2$) constitutes a positive Feature 3.
• Feature 4: Disorganized Thinking: Evaluated if Feature 3 is negative (current RASS is 0). The patient is asked 4 simple logic questions (e.g., "Will a stone float on water?", "Are there fish in the sea?", "Does one pound weigh more than two pounds?", "Can you use a hammer to pound a nail?") and instructed to follow a command ("Hold up this many fingers"). More than 1 error indicates disorganized thinking.
• Diagnostic Rule: Delirium is confirmed if Feature 1 AND Feature 2 are present, PLUS EITHER Feature 3 OR Feature 4.

3. Prevention and Management

• Non-Pharmacological Bundle (Primary Therapy): Early physical therapy and mobilization, promotion of normal sleep architecture (minimizing nighttime noise, clustering nursing care, keeping room lights on during the day and off at night), frequent cognitive reorientation, providing sensory aids (eyeglasses, hearing aids), early removal of physical restraints and invasive catheters.
• Pharmacological Recommendations: PADIS guidelines explicitly advise against the routine prophylactic administration of antipsychotics (haloperidol, quetiapine, olanzapine) to prevent or treat delirium. Antipsychotics should be reserved strictly for short-term control of severe agitation that threatens patient or staff safety.

Liberation from Mechanical Ventilation and Weaning Predictors

Weaning is the process of gradually transitioning a patient from full mechanical ventilatory support to unassisted spontaneous breathing and extubation.

1. Readiness Criteria for a Spontaneous Breathing Trial (SBT)

Before initiating an SBT, the patient must fulfill objective physiological readiness criteria:

• Resolution or Substantial Improvement: The underlying acute respiratory pathology that necessitated intubation has stabilized or improved.
• Adequate Oxygenation: $P_a\text{O}_2/F_i\text{O}_2 \ge 150-200\text{ mmHg}$ on $\text{PEEP} \le 5-8\text{ cm}\text{H}_2\text{O}$ and $F_i\text{O}_2 \le 0.40-0.50$, with arterial $pH \ge 7.30$.
• Hemodynamic Stability: Absence of active myocardial ischemia; low or no vasopressor support (e.g., dopamine $<5\text{ mcg/kg/min}$ or norepinephrine $<0.05-0.1\text{ mcg/kg/min}$).
• Neurological and Airway Adequacy: Patient is arousable, cooperative, able to follow commands (GCS $\ge 8-9$), has strong protective airway reflexes (vigorous cough on endotracheal suctioning), and manageable volume/viscosity of tracheobronchial secretions.

2. The Spontaneous Breathing Trial (SBT)

• Technique: Performed for $30\text{ to }120\text{ minutes}$ using either a T-piece circuit or low-level pressure support ventilation (PSV of $\le 5-7\text{ cm}\text{H}_2\text{O}$ with PEEP $0-5\text{ cm}\text{H}_2\text{O}$).
• Failure Criteria: Respiratory rate $>35\text{ breaths/min}$ or $<8\text{ breaths/min}$; $S_p\text{O}_2 < 90\%$; heart rate $>140\text{ bpm}$ or $>20\%\text{ change}$ from baseline; systolic blood pressure $>180\text{ mmHg}$ or $<90\text{ mmHg}$; development of diaphoresis, intercostal indrawing, thoracoabdominal paradox, or new cardiac dysrhythmias.

3. The Rapid Shallow Breathing Index (RSBI / Yang-Tobin Index)

The RSBI is the most widely validated objective physiological predictor of extubation success:

$\text{RSBI} = \frac{f}{V_T}$

Where $f$ is the spontaneous respiratory rate in breaths per minute, and $V_T$ is the spontaneous tidal volume in liters, measured during $1\text{ minute}$ of unassisted breathing through a T-piece or a spirometer connected to the endotracheal tube.

• $\text{RSBI} < 105\text{ breaths/min/L}$: Predicts successful weaning and extubation (high sensitivity $\approx 97\%$, moderate specificity).
• $\text{RSBI} > 105\text{ breaths/min/L}$: Strongly predictive of weaning failure. Reflects rapid, shallow ventilatory mechanics driven by diaphragmatic fatigue, decreased respiratory compliance, or elevated dead space.

4. Cuff-Leak Test and Post-Extubation Stridor

• Cuff-Leak Test: Deflating the endotracheal tube cuff during volume-controlled ventilation to assess for peritubal air leak around the tube. An absolute cuff-leak volume $<110-130\text{ mL}$ (or $<15-24\%$ of delivered tidal volume) indicates severe laryngeal edema and high risk of post-extubation stridor and re-intubation.
• Prevention: In high-risk patients with a failed cuff-leak test, administering intravenous corticosteroids (e.g., methylprednisolone $20-40\text{ mg}$ IV every 4–6 hours) initiated at least $4\text{ to }6\text{ hours}$ prior to extubation significantly reduces laryngeal edema and post-extubation stridor.

---

Determination of Death by Neurological Criteria (Brain Death)

Brain death represents the complete, irreversible cessation of all functions of the entire brain, including the brainstem. The determination is fundamentally a clinical diagnosis that requires strict adherence to standardized legal-medical prerequisites.

1. Mandatory Prerequisites (Confounders Must Be Excluded)

Prior to initiating brainstem reflex testing, the following conditions must be fulfilled:

1. Established, Irreversible Brain Damage: An established, documented catastrophic structural or anoxic etiology sufficient to account for brain death (e.g., massive intraparenchymal hemorrhage, severe traumatic brain injury, confirmed anoxic encephalopathy post-cardiac arrest).
2. Adequate Core Temperature: The threshold varies by national code: $\ge 36\text{°C}$ in the World Brain Death Project (2020) and the 2023 US adult and paediatric guideline, but $> 34\text{°C}$ in the UK Academy of Medical Royal Colleges code (2008). Severe hypothermia suppresses neuronal conduction and abolishes brainstem reflexes.
3. Hemodynamic Stability: Systolic blood pressure must be $\ge 100\text{ mmHg}$ or mean arterial pressure $\ge 60-65\text{ mmHg}$. Vasopressors or inotropes may be titrated to achieve this threshold.
4. Exclusion of Metabolic and Endocrine Confounders: Severe electrolyte abnormalities (e.g., profound hyponatremia/hypernatremia), profound hypoglycemia, severe acid-base disturbances, hepatic failure, uremic encephalopathy, severe hypothyroidism (myxedema coma), and adrenal crisis must be excluded or corrected.
5. Exclusion of Neuromuscular Blockade and CNS Depressants:
   • Absence of residual neuromuscular blockade confirmed by Train-of-Four (TOF) peripheral nerve stimulation demonstrating $4/4$ robust twitches.
   • Complete clearance of all central depressant drugs (sedatives, opioids, barbiturates, anticholinergics). Clinicians must confirm either negative toxicological drug levels or allow the passage of at least $5\text{ elimination half-lives}$, calculated taking into account hypothermia-induced enzyme impairment, hepatic dysfunction, or renal failure.

2. Clinical Brainstem Reflex Examination (Must Be Completely Absent)

Spinal Reflexes vs Brain Death: Spinally mediated motor reflexes (e.g., deep tendon reflexes, superficial abdominal reflexes, triple flexion withdrawal of lower extremities, and the Lazarus sign—complex spinal reflex flexion of the arms and torso upon neck flexion or hypoxic stimulus) originate within the isolated spinal cord and do NOT preclude or invalidate the diagnosis of brain death.

3. The Apnea Test Protocol

The apnea test confirms the complete absence of spontaneous respiratory drive when the medullary respiratory center is subjected to maximum hypercapnic stimulation.

• Prerequisites: Core temperature above the national threshold (for example $\ge 36\text{°C}$ under World Brain Death Project and US criteria), systolic blood pressure $\ge 100\text{ mmHg}$, normovolemia, baseline normocapnia ($P_a\text{CO}_2\text{ }35-45\text{ mmHg}$), and pre-oxygenation with $1.0\text{ }F_i\text{O}_2$ for $10-15\text{ minutes}$ to achieve a $P_a\text{O}_2 \ge 200\text{ mmHg}$.
• Procedure: Disconnect the patient from the mechanical ventilator. Deliver continuous insufflation of $100\%\text{ O}_2$ at $6\text{ L/min}$ via a catheter positioned at the level of the carina (or use a CPAP valve circuit with PEEP $5\text{ cm}\text{H}_2\text{O}$ to prevent derecruitment). Observe the chest and abdomen continuously for $8\text{ to }10\text{ minutes}$ for any spontaneous respiratory effort. At $100\%$ oxygenation, $P_a\text{CO}_2$ rises at approximately $2-3\text{ mmHg/minute}$.
• Confirmation of Brain Death (Positive Test):
  1. Complete absence of spontaneous respiratory effort (no breathing, no gasping);
  2. Post-test arterial blood gas reaches the hypercapnic target: $P_a\text{CO}_2 \ge 60\text{ mmHg}$ with $pH < 7.30$ (World Brain Death Project 2020); the 2023 US guideline requires $P_a\text{CO}_2 \ge 60\text{ mmHg}$ and a rise of $\ge 20\text{ mmHg}$ above baseline, with $pH \le 7.30$;
  3. The UK code instead starts from $P_a\text{CO}_2 > 6.0\text{ kPa}$ with $pH < 7.40$ and requires a rise of $> 0.5\text{ kPa}$ during 5 minutes of apnoea. Always apply the national criteria in force.
• Criteria to Abort Test: If severe arterial hypotension ($\text{SBP} < 90\text{ mmHg}$), significant arterial desaturation ($S_p\text{O}_2 < 85\%$), or malignant cardiac dysrhythmias develop, immediately draw an arterial blood gas, reconnect the ventilator with $100\%\text{ O}_2$, and abort the test. If the blood gas does not fulfill the $P_a\text{CO}_2$ threshold, the test is deemed inconclusive and an ancillary test must be performed.

4. Ancillary (Confirmatory) Tests

Ancillary tests are not mandatory in typical clinical examinations, but are legally and medically required when:

• The clinical examination cannot be completed (e.g., severe facial trauma precluding cranial nerve assessment, cervical spine trauma);
• The apnea test cannot be safely completed or tolerated due to severe hemodynamic collapse or refractory hypoxemia;
• Significant metabolic or pharmacological confounders (e.g., barbiturate therapy) cannot be cleared.

---

Clinical Pearls and Exam Traps

• The Lazarus Sign Trap: Spinal cord reflexes can mimic voluntary or involuntary movement. Movements such as triple flexion, deep tendon reflexes, and the Lazarus sign (spontaneous arm flexion across the chest upon apnea stimulation) originate in the spinal cord, which receives blood supply from segmental spinal arteries. They do not indicate brainstem activity and do not rule out brain death.
• PRIS Warning Signs: In patients receiving propofol, unexplained widening anion gap metabolic acidosis, hyperkalemia, or new right bundle branch block/Brugada-like ST elevations are critical warning signs of Propofol Infusion Syndrome (PRIS). The infusion must be discontinued immediately.
• Temperature Rule in Brain Death: At a core temperature of $34\text{°C}$, testing cannot proceed under World Brain Death Project or US criteria, which require $\ge 36\text{°C}$ (the UK code requires $> 34\text{°C}$). Rewarm the patient to the applicable threshold before cranial nerve or apnea testing.